BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/11/2014 8:39:00 PM | Browse: 459 | Download: 311
Publication Name World Journal of Gastroenterology
Manuscript ID 5264
Country of Manuscript Source Brazil
Received
2013-08-26 10:43
Peer-Review Started
2013-08-26 14:38
To Make the First Decision
2013-09-09 16:58
Return for Revision
2013-09-11 07:54
Revised
2013-09-28 06:22
Second Decision
2013-10-14 09:54
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2013-10-14 13:19
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
2013-11-09 02:08
Typeset the Manuscript
2013-12-04 14:42
Publish the Manuscript Online
2013-12-18 10:00
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Specialty Gastroenterology and Hepatology
Manuscript type Review
Article Title Pathophysiology of cystic fibrosis and drugs used in associated digestive tract diseases
Manuscript Source Invited Manuscript
All Author List Adriana Haack, Giselle Gonçalves Aragão and Maria Rita Carvalho Garbi Novaes
Funding Agency and Grant Number
Corresponding author Adriana Haack, Professor of Nutrition, Department of Health, Universidade Paulista (UNIP), SHIGS 715 Block A House 87, Brasília Federal District, Brasília 70381701, Brazil. adrianahaack@hotmail.com
Keywords Cystic fibrosis; Medication; Therapeutic; Absorption; Digestion
Core Tip Cystic fibrosis (CF) has been studied in Brazil and in many other countries. Digestive manifestations may significantly compromise the nutritional status of CF patients, leading to numerous symptoms. Supplementation with enzymes, vitamins and nutrients is usually necessary. When infections are present, antibiotics are necessary, and these infections are often multisystemic, involving the digestive tract. The pharmaceutical assistance included in public policies, especially those which are financed, and the constant incentive to study the digestive manifestations in CF patients are essential, as without them, there would be infinite clinical changes which would compromise patient survival.
Publish Date 2013-12-18 10:00
Citation Haack A, Aragão GG, Novaes MRCG. Pathophysiology of cystic fibrosis and drugs used in associated digestive tract diseases. World J Gastroenterol 2013; 19(46): 8552-8561
Url http://www.wjgnet.com/1007-9327/full/v19/i46/8552.htm
DOI http://dx.doi.org/10.3748/wjg.v19.i46.8552
Full Article (PDF) WJG-19-8552.pdf
Manuscript File 5264-Review.doc
Answering Reviewers 5264-Answering reviewers.pdf
Copyright License Agreement 5264-Copyright assignment.pdf
Peer-review Report 5264-Peer review(s).pdf
Scientific Editor Work List 5264-Scientific editor work list.doc